Fingerprint
Dive into the research topics of 'Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 2 trial of everolimus and letrozole in relapsed estrogen receptor-positive high-grade ovarian cancers
Gerardo Colon-Otero, Saravut (John) Weroha, Nathan R. Foster, Paul Haluska, Xiaonan Hou, Andrea E Wahner Hendrickson, Aminah Jatoi, Matthew S Block, Tri A. Dinh, Matthew W. Robertson, John A III Copland
Research output: Contribution to journal › Article › peer-review
16
Scopus
citations